1.17000 EUR
0.04
3.54%
Last update Dec 12, 7:31 PM CET
Market closed
Day range
1.14000
1.20000
Previous close
1.13000
Open
1.18000
Access this stock data via API
Subscribe
InMed Pharmaceuticals Inc.
1.17
0.04
3.54%

Financials

Income statement

Fundamentals currency is USD
Fiscal date 2025 2024 2023 2022
Total reported revenue 4.2M 3.9M 6.0M 1.6M
Cost of revenue 2.8M 3.0M 3.9M 787.0K
Gross profit 1.5M 940.3K 2.0M 783.6K
Operating expense
Research & development 2.4M 3.2M 5.4M 10.5M
Selling general and admin 5.6M 4.5M 8.4M 9.9M
Other operating expenses
Operating income -6.7M -6.9M -12.1M -19.9M
Non operating interest income
Income 132.8K 450.9K 710.0K 138.5K
Expense 316.5K 0
Other income expense -24.3K -52.9K -69.5K -7.1M
Pretax income -7.0M -6.5M -11.4M -26.8M
Tax provision 0 6.1K 18.9K 0
Net income -7.0M -6.6M -11.5M -26.8M
Basic EPS -8.4 -20.2 -65 -663.4
Diluted EPS -8.4 -20.2 -65 -663.4
Basic average shares 831.3K 325.5K 186.1K 42.6K
Diluted average shares 831.3K 325.5K 186.1K 42.6K
EBITDA -6.2M -6.4M -11.2M -12.1M
Net income from continuing op. -7.0M -6.6M -11.5M -26.8M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed
Main market opens in 2 hours 28 minutes

05:31
00:00
08:00
20:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 20:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).